Novo Nordisk A/S
- Country
- 🇩🇰Denmark
- Ownership
- Public
- Established
- 1923-01-01
- Employees
- 63.3K
- Market Cap
- $602.2B
- Website
- http://www.novonordisk.com
A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)
- Conditions
- Interventions
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 582
- Registration Number
- NCT04848480
- Locations
- 🇯🇵
Yuri Ono Clinic, Sapporo-shi, Hokkaido, Japan
🇬🇧Churchill Hospital, Oxford, United Kingdom
🇬🇧Lister Hospital, Stevenage, United Kingdom
GOAL: A Research Study Looking at Long Term Blood Sugar Control in People With Type 2 Diabetes Treated With Xultophy® in Local Clinical Practice in Japan.
- First Posted Date
- 2021-04-09
- Last Posted Date
- 2024-01-26
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 244
- Registration Number
- NCT04838743
- Locations
- 🇯🇵
Budounoki Clinic, Saga-shi, Saga, Japan
🇯🇵Seino Internal Medicine Clinic, Koriyama-shi, Fukushima, Japan, Japan
🇯🇵Kawada Clinic, Gunma, Japan
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
- Conditions
- Interventions
- First Posted Date
- 2021-03-30
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 1200
- Registration Number
- NCT04822181
- Locations
- 🇰🇷
Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of
🇰🇷Chung-Ang University Hospital, Seoul, Korea, Republic of
🇲🇾Hospital Selayang, Batu Caves, Malaysia
A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets
- First Posted Date
- 2021-03-26
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 14
- Registration Number
- NCT04817644
- Locations
- 🇺🇸
ICON Early Phase Services, LLC, San Antonio, Texas, United States
🇺🇸ICON-Salt Lake City, Millcreek, Utah, United States
Remote Study Collecting Blood Glucose Values and Activity Data in Patients With Type 2 Diabetes on Different Treatments
- Conditions
- Interventions
- First Posted Date
- 2021-03-22
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 150
- Registration Number
- NCT04809311
- Locations
- 🇩🇰
Digital/virtual site, Copenhegan, Denmark
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)
- Conditions
- Interventions
- First Posted Date
- 2021-03-12
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 588
- Registration Number
- NCT04795531
- Locations
- 🇨🇳
Novo Nordisk Investigational Site, Taipei, Taiwan
🇺🇸Lakeview Clinical Research, LLC, Guntersville, Alabama, United States
🇺🇸American Clinical Trials, Buena Park, California, United States
Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity
- First Posted Date
- 2021-03-09
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 529
- Registration Number
- NCT04788511
- Locations
- 🇺🇸
John Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸Eastern Shore Rsrch Inst, LLC, Fairhope, Alabama, United States
🇺🇸Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
- Conditions
- Interventions
- First Posted Date
- 2021-03-02
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 1840
- Registration Number
- NCT04777409
- Locations
- 🇦🇺
HammondCare Greenwich, Greenwich, New South Wales, Australia
🇬🇧NeuroClin, Motherwell, United Kingdom
🇺🇸Banner Alzheimer's Institute, Phoenix, Arizona, United States
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
- Conditions
- Interventions
- First Posted Date
- 2021-03-02
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 1840
- Registration Number
- NCT04777396
- Locations
- 🇬🇧
NeuroClin, Motherwell, United Kingdom
🇺🇸Banner Alzheimer's Institute, Phoenix, Arizona, United States
🇺🇸Imaging Endpoints, Scottsdale, Arizona, United States
SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity
- First Posted Date
- 2021-03-01
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 78
- Registration Number
- NCT04775082
- Locations
- 🇺🇸
University of Minnesota_CPOM, Minneapolis, Minnesota, United States
🇺🇸UPMC Child Hosp-Pittsburgh, Pittsburgh, Pennsylvania, United States
🇲🇽Consultorio de Endocrinología y Pediatría, Puebla, Mexico